GeneTether Therapeutics Announces Binding Term Sheet for Private Placement of Units and Exclusive License Agreement of Soft Tissue Sarcoma Drug Candidate

Stock Information for Bedford Metals Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Bedford Metals Corp.

CSE Bulletin: Name and Symbol Change - GeneTether Therapeutics Inc. (GTTX)
GeneTether Therapeutics Announces Name Change to Rize Oncology, Reflecting New Focus on Oncology
GeneTether Therapeutics Announces Closing of Licensing Agreement for STS-201 and $500,000 Non-Brokered Private Placement
GeneTether Therapeutics Inc. Announces Results of Shareholder Meeting
GeneTether Therapeutics Provides Supplementary Information Concerning License Agreement
GeneTether Therapeutics Inc. Announces Arrangements to Address Mailing Delays from Canada Post Strike
GeneTether Therapeutics Inc. Announces Third Quarter 2024 Financial Results
GeneTether Therapeutics Inc. Announces Second Quarter 2024 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.